5th December 2019
Italian, Polish and Portuguese teams on the podium.
Restorative Neurotechnologies, a spin-off from the University of Palermo, has won first place in the EIT Health HeadStart support 2019 with Mindlenses Professional, a project for cognitive rehabilitation. SensoriumLab and Delox also on the podium!
The EIT Health Headstart Programme provides funding of up to €50 000 to support early-stage companies and small and medium enterprises in developing new products and services. Selected companies work on their product launch project with support from the regional managers to access local and EIT Health networks. The purpose of the EIT Health Headstart Funding Programme is to: support applicants in developing the next steps in reaching the market and shortening time-to-market for innovative products and services; verify the need/benefit of the product/service for users/customers/payers/partners and increase the possibility of attracting further private investment. Addressing challenges such as heart disease, Parkinson’s, geriatric care and molecular diagnoses, these projects come from Italy, Poland, Portugal and Greece. What they have in common is the goal to improve healthcare for us all. The three winning start-ups include Restorative Neurotechnologies , SensoriumLab, and Delox.
Restorative Neurotechnologies, a spin-off from the University of Palermo, gave birth to Mindlenses Professional, a project for cognitive rehabilitation. Mindlenses is a complete combination of cognitive stimulation, digital rehabilitation and digitalised user management. It includes a user management platform, and a tablet for carrying out digital evaluation and cognitive exercises. Restorative Neurotechnologies won not only first prize at the EIT Health HeadStart 2019 but also a booth at StartupVillage at the EIT Health Summit which took place in Paris in December, with the chance to meet investors and establish new collaborations with the EIT Health Partners.
SensoriumLab is a Polish company that offers a user-friendly and non-invasive diagnostic system for assessment of pleural effusion (water on lungs). The device makes it possible to monitor patients remotely, and the monitoring can even be handled by non-professionals.
Delox was created as a spin-off in the Faculdade de Ciências da Universidade de Lisboa, Portugal (FCUL) in June 2018. The company designs and develops a new generation of bio-decontamination devices to fight all types of microorganisms. Completely based on proprietary technology, the solution offers automatic bio-decontamination for everyone, everywhere.
NALA.care joins forces with La Roche-Posay
Discover how the partnership will benefit patients
Leuko closes €5M Series A round
Learn more about Leuko and its achievements
EIT Health appoints three new Supervisory Board members
Join us in welcoming our new Board members